Brief: Almirall And Absci Expand AI Drug Creation Collaboration Adding Second Dermatology Target
Aug 7 (Reuters) - Almirall SA ALM.MC: ALMIRALL AND ABSCI EXPAND AI DRUG CREATION COLLABORATION ADDING SECOND DERMATOLOGY TARGET ABSCI ELIGIBLE FOR UP TO $650 MILLION IN PAYMENTS SELECTS SECOND TARGET AIMED AT DERMATOLOGICAL INDICATIONS IN AI DRUG COLLABORATION Source text: ID:nGNXN549D Further company coverage: ALM.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on AbSci
See all newsAbsci Corp reports results for the quarter ended September 30 - Earnings Summary
Brief: Absci Corp Files For Mixed Shelf Size Not Disclosed - SEC Filing
Absci Q3 revenue misses estimates, net loss widens on R&D spends
Focus: Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave